Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan-Dec:27:1076029620975484.
doi: 10.1177/1076029620975484.

Solid Tumor Complicated With Venous Thromboembolism: A 10-Year Retrospective Cross-Sectional Study

Affiliations

Solid Tumor Complicated With Venous Thromboembolism: A 10-Year Retrospective Cross-Sectional Study

Miao Peng et al. Clin Appl Thromb Hemost. 2021 Jan-Dec.

Abstract

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT) occurs more frequently in cancer patients than in the general population. A retrospective cross-sectional study was carried out in patients with solid tumor complicated with VTE admitted to the Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology between January 1st, 2008 and December 31th, 2017. The incidence of VTE in hospitalized cancer patients was 1.8%, twice the incidence of VTE in hospitalized non-cancer patients. The annual incidence of cancer-associated VTE in our center varied between 1.6% in 2015 and 0.4% in 2009 with an overall average incidence of 1.3% over the research decade. BMI values of 549(67.7%) cancer patients were within the normal range, but none of patients had BMI greater than 35 kg/m2. 747(92.1%) cancer patients had ECOG PS score ≤ 2 and 481(59.3%) had distant metastasis. Patients with pancreatic, bladder, ovarian and endometrial cancer had the highest incidence of VTE. Upper extremity DVT (47.2%) was more common in cancer patients and might be closely associated with CVC (74.9%), while lower extremities DVT (36.1%) intended to PE development (15.0%). The annual incidence rates showed a fluctuating and upward trend over the research decade. VTE occurrence was closely related to tumor stage, tumor site, catheterization and anti-neoplasm therapy in cancer patients.

Keywords: DVT; PE; VTE; cancer; pulmonary embolism; venous thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Clinical features of VTE: A. composition of cancer subtypes inVTE patients with malignancy. clinical features of VTE: B The blue ellipse represented DVT developed in the upper limbs, the yellow ellipse represented DVT developed in the lower limbs, the green ellipse represented DVT developed in the splanchnic veins and the red ellipse represented DVT developed in the neck or thorax. The overlap area represented that the site of DVT located in 2 anatomic parts of the body. (ULDVT: upper limb DVT, LLDVT: lower limb DVT, SPDVT: splanchnic DVT, N&T DVT: neck and thoracic DVT).

Similar articles

Cited by

References

    1. MacLellan DG, Richardson A, Stoodley MA. Venous thromboembolism and cancer. ANZ J Surg. 2012;82(5):294–298. - PubMed
    1. Nisio M, Di Nisio M, Ferrante N, et al. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemostas. 2010;104(11):1049–1054. - PubMed
    1. Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation. 2003;107(23_suppl_1):I17–I21. - PubMed
    1. Schmaier AA, Ambesh P, Campia U. Venous thromboembolism and cancer. Curr Cardiol Rep. 2018;20(10):89. - PubMed
    1. Connors JM. Prophylaxis against venous thromboembolism in ambulatory patients with cancer. N Eng J Med. 2014. 370(26):2515–2519. - PubMed

LinkOut - more resources